SEC Filing Analysis: Coeptis Therapeutics Holdings, Inc. (COEP)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director filed a notice of intent to sell a small amount of stock, valued at $75,100, which is not a material event for the company.
• Market Impact: The transaction is minor relative to the company's market capitalization and is unlikely to have a significant impact on the stock price.

Company Information

Field	Value
Company	Coeptis Therapeutics Holdings, Inc.
Ticker Symbol	COEP
CIK	0001759186
Industry	FINANCE SERVICES

Insider Information

Field	Value
Name	Yerace Daniel Alexander
CIK	0001846625
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	144
Transaction Date	2025-12-15
Transaction Code	null
Security Type	Common
Shares Involved	5000
Price Per Share	$15.02
Total Value	$75,100
Shares Owned After	null
Ownership Type	null

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$75,100
% of Market Cap	0.11%
Shares Transacted	5,000
% of Shares Outstanding	0.026%
Post-Transaction Ownership	Not Disclosed
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For Coeptis Therapeutics, a company with a market capitalization of approximately $70 million, this $75,100 transaction is minor, representing just over 0.1% of its total market value.
• Ownership Concentration: The filing does not disclose post-transaction ownership, so a change in ownership concentration cannot be assessed. However, the number of shares being sold is a very small fraction (0.026%) of the total shares outstanding (19,516,373).
• Transaction Significance: The transaction falls well below the thresholds for high significance (>1% of market cap or >0.5% of shares outstanding). It is considered a routine, non-material event.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: A Form 144 is a notice of intent to sell, not a completed sale. The size of the proposed sale is insignificant relative to the company's market capitalization and daily trading volume. It is unlikely to influence investor sentiment or stock price.

Volume & Sentiment

• Expected Volume Impact: Minimal. The 5,000 shares can likely be absorbed by the market without a noticeable impact on trading volume.
• Sentiment Indicator: Neutral. This small, planned sale by a director does not signal a change in the company's outlook.

Additional Context

Transaction Notes

• Special Circumstances: The filing indicates this proposed sale is pursuant to a trading plan adopted on May 21, 2025, which suggests it is a pre-scheduled transaction and not based on immediate market events.